/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Monica Andreoli

Arvinas (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

23

Papers

633

Citations

8

h-index

8

i10-index

Monica Andreoli is an academic researcher from Arvinas (United States). The author has contributed to research in topics: Protein Degradation and Inhibitors & Advanced Breast Cancer Therapies & Histone Deacetylase Inhibitors Research. The author has an h-index of 8, co-authored 20 publications.

ORCID: 0009-0003-6115-357X

Research Topics

Protein Degradation and Inhibitors Advanced Breast Cancer Therapies Histone Deacetylase Inhibitors Research Amino Acid Enzymes and Metabolism Nitric Oxide and Endothelin Effects

Papers by this author

works

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models

2024 · Clinical Cancer Research · 132 citations

https://doi.org/10.1158/1078-0432.ccr-23-3465

Sheryl M. Gough John J. Flanagan Jessica L.F. Teh Monica Andreoli

A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity

2019 · Journal of Biological Chemistry · 37 citations

https://doi.org/10.1074/jbc.ra119.009860

Pathricia V. Tilstam Georgios Pantouris Michael L. Corman Monica Andreoli

Research topics

topics

Protein Degradation and Inhibitors

Advanced Breast Cancer Therapies

Histone Deacetylase Inhibitors Research

Amino Acid Enzymes and Metabolism

Nitric Oxide and Endothelin Effects

Chat about Author

Papers

Chat

Click to start Chat